Review highlights macc1-as1's role in oncogenesis and suggests it as a promising cancer treatment target.
Key Points
Overexpression of macc1-as1 is linked to larger tumor size and poorer overall survival rates, complicating treatment options.
The study shows that long non-coding RNAs, such as macc1-as1, can function both as tumor promoters and inhibitors, indicating their complex role in cancer.
In-depth analysis explores macc1-as1's multiple interactions with proteins and its influence on various biological pathways, advancing our understanding of cancer.
Identifying macc1-as1 as a potential biomarker may enable more effective cancer treatment strategies and improve therapeutic outcomes.